Perceptive Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-400,000
| Closed | -$2.16M | – | 138 |
|
|
2020
Q4 | $2.16M | Hold |
400,000
| – | – | 0.02% | 128 |
|
|
2020
Q3 | $3.19M | Hold |
400,000
| – | – | 0.05% | 106 |
|
|
2020
Q2 | $4M | Buy |
+400,000
| New | +$4M | 0.06% | 98 |
|
|
2018
Q3 | – | Sell |
-49,302
| Closed | -$585K | – | 115 |
|
|
2018
Q2 | $585K | Buy |
+49,302
| New | +$585K | 0.02% | 106 |
|